Assembly Biosciences Inc.

20.42-0.7600-3.59%Vol 189.42K1Y Perf -9.92%
Feb 14th, 2020 16:00
BID20.39 ASK20.42
Open21.25 Previous Close21.18
Pre-Market- After-Market20.42
 - -%  - -%
Target Price
38.00 
Analyst Rating
Strong Buy 1.00
Potential %
86.09 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Market Cap531.88M 
Earnings Rating
Sell
Price Range Ratio 52W %
72.55 
Earnings Date
27th Feb 2020

Today's Price Range

20.2021.47

52W Range

8.1325.07

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
0.10%
1 Month
14.01%
3 Months
57.08%
6 Months
66.29%
1 Year
-9.92%
3 Years
0.99%
5 Years
95.22%
10 Years
-

TickerPriceChg.Chg.%
ASMB20.42-0.7600-3.59
AAPL324.950.08000.02
GOOG1 520.746.08000.40
MSFT185.351.64000.89
XOM60.64-0.2900-0.48
WFC48.220.10000.21
JNJ150.130.04000.03
FB214.181.04000.49
GE12.83-0.1100-0.85
JPM137.46-0.4200-0.30
Earnings HistoryEstimateReportedSurprise %
Q03 2019-0.93-0.96-3.23
Q02 2019-1.10-0.7234.55
Q01 2019-1.07-1.051.87
Q04 2018-0.91-1.03-13.19
Q03 2018-1.02-0.8714.71
Q02 2018-0.90-1.30-44.44
Q01 2018-0.76-0.80-5.26
Q04 2017--0.16-
Earnings Per EndEstimateRevision %Trend
12/2019 QR-1.010.00-
12/2019 FY-3.574.80Positive
3/2020 QR-0.960.00-
12/2020 FY-4.160.00-
Next Report Date27th Feb 2020
Estimated EPS Next Report-1.01
Estimates Count4
EPS Growth Next 5 Years %-
Volume Overview
Volume189.42K
Shares Outstanding26.05M
Trades Count2.61K
Dollar Volume4.48M
Avg. Volume303.45K
Avg. Weekly Volume262.55K
Avg. Monthly Volume274.70K
Avg. Quarterly Volume472.59K
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
5 (100.00 %)
5 (100.00 %)
5 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical stage biotechnology company. It is advancing two innovative platform programs, a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein.

CEO: John G McHutchison

Teplephone: +1 317 210-9311

Address: 11711 North Meridian Street, Carmel 46032, IN, USA

Number of employees: 107

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

60%40%

Bearish Bullish

58%42%

Bearish Bullish

45%55%

News

Stocktwits